Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of PAD ciclosporin ophthalmic dispersion plus lubricant therapy in moderate to severe dry eye disease
2015-000937-54Phase 2Completed
- Sponsor
- Catalent
- Start
- Apr 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cyclosporine in dry eye syndrome (DED) (4 arms), sponsored by Catalent. Started Apr 2015; status: completed.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on 2015-000937-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000937-54.